| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/03/1996 | EP0690070A1 Indole-containing peptide and process for preparing the same |
| 01/03/1996 | EP0689845A2 Conjugates of methyltrithio antitumor agents and intermediates for their synthesis |
| 01/03/1996 | EP0689843A1 Composition containing soluble thrombomodulins |
| 01/03/1996 | EP0689604A1 Process for preparing cancer vaccines |
| 01/03/1996 | EP0689603A1 Defective mutant non-retroviral virus (e.g. hsv) as vaccine |
| 01/03/1996 | EP0689602A1 Delivery system controlled through factors associated with hiv and cell |
| 01/03/1996 | EP0689600A1 Process to induce the death of tumor cells |
| 01/03/1996 | EP0689599A1 Chimeric selectin by exchange of domains - uses thereof |
| 01/03/1996 | EP0689597A1 USE OF PORCINE GAL $g(a)(1,3) GALACTOSYL TRANSFERASE IN XENOGRAFT THERAPIES |
| 01/03/1996 | EP0689596A1 Stimulation of immune response by viral protein |
| 01/03/1996 | EP0689593A1 Inhibition of selected tumor growth with recombinant viral sector |
| 01/03/1996 | EP0689592A1 Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same |
| 01/03/1996 | EP0689590A1 Totally synthetic affinity reagents |
| 01/03/1996 | EP0689588A1 Extracellular signal-regulated kinase, sequences, and methods of production and use |
| 01/03/1996 | EP0689586A1 Vpr function and activity |
| 01/03/1996 | EP0689551A1 Immunogenic chimeras comprising nucleic acid sequences encoding endoplasmic reticulum signal sequence peptides and at least one other peptide, and their uses in vaccines and disease treatments |
| 01/03/1996 | EP0689550A1 Novel antimicrobial peptides from bovine neutrophils |
| 01/03/1996 | EP0689549A1 New urea derivates, their preparation and their use |
| 01/03/1996 | EP0689547A1 Cloned human alpha1c adrenergic receptor |
| 01/03/1996 | EP0689460A1 Cyclobutyl antisense oligonucleotides, methods of making and use thereof |
| 01/03/1996 | EP0689459A1 Novel agent for controlling cell activity |
| 01/03/1996 | EP0689452A1 Composition for oral administration of peptides |
| 01/03/1996 | EP0689451A1 Pharmaceutical compositions comprising a ligand complexed with a soluble receptor |
| 01/03/1996 | EP0689450A1 Potassium channel blocking compounds and their use |
| 01/03/1996 | EP0689449A1 Therapeutical compositions for use in humans, characterised by a combination of a muramyl peptide and a cytokine |
| 01/03/1996 | EP0689448A1 Angiogenine, and/or alpha1-microglobuline and/or complementary factor d for limiting protein secretion |
| 01/03/1996 | EP0689433A1 Novel metal binding agents, and methods and compositions for their use to treat metal toxicity |
| 01/03/1996 | EP0689430A1 Superparamagnetic particles, process for producing the same and their use |
| 01/03/1996 | EP0689428A1 Enhanced circulation effector composition and method |
| 01/03/1996 | EP0689421A1 Reduced and controlled surface binding of biologically active molecules |
| 01/03/1996 | EP0580685B1 Pharmaceutical packaging unit containing plasminogen activators for multiple-bolus administration |
| 01/03/1996 | EP0544712B1 Neuraminidase and galactose oxidase as vaccine adjuvant |
| 01/03/1996 | EP0498851B1 Urinary tumor associated antigen, antigenic subunits uses and methods of detection |
| 01/03/1996 | EP0478602B1 Expression of tetanus toxin fragment c |
| 01/03/1996 | EP0473701B1 Recombinant dna method for production of parathyroid hormone |
| 01/03/1996 | EP0440686B1 Peptides representing epitopic sites on r-ifn-beta, antibodies thereto, and uses thereof |
| 01/03/1996 | EP0275300B1 Recombinant vaccine |
| 01/03/1996 | CN1114321A Chemical compounds |
| 01/02/1996 | US5481030 Phosphonic acid compounds |
| 01/02/1996 | US5481021 Phenyl amidines derivatives useful as platelet aggregation inhibitors |
| 01/02/1996 | US5480981 Hodgkin's disease |
| 01/02/1996 | US5480974 Blocking agents, antiinflammatory |
| 01/02/1996 | US5480972 Diagnosing, treating and preventing sensitivity; dna sequences |
| 01/02/1996 | US5480970 Radioactive materials for labels in diagnosis of tumors in tissues |
| 01/02/1996 | US5480969 Luteinizing hormone releasing hormone antagonists similar to antide and congeners with higher water solubility due to hydrophilic residue substitutions in positions 1, 5 or 6; antiovulatory activity with minimal histamine-releasing effect |
| 01/02/1996 | US5480968 Isolated polypeptide erbB-3, related to the epidermal growth factor receptor and antibody thereto |
| 01/02/1996 | US5480893 Antitumor |
| 01/02/1996 | US5480888 1,2-benzoisoselenazol-3-(2h)-(thi)one derivatives |
| 01/02/1996 | US5480872 Method of providing enternal nutritional support to persons infected with human immunodeficiency virus |
| 01/02/1996 | US5480870 Heptapeptide and octapeptide amide derivatives; treatment of excessive secretion of insulin, glucagon or growth hormone |
| 01/02/1996 | US5480869 Anti-inflammatory peptide analogs and treatment to inhibit vascular leakage in injured tissues |
| 01/02/1996 | US5480868 Sustained-release preparation |
| 01/02/1996 | US5480867 Glucagon analogs with serine replacements |
| 01/02/1996 | US5480866 Administering hemoglobin |
| 01/02/1996 | US5480864 Modified maxadilan fusion protein containing a thrombin cleavage site; composition for topical application to mammals' skin comprises modified maxadilan protein as vasodilator in vehicle |
| 01/02/1996 | US5480799 Sperm antigen corresponding to a sperm zona binding protein autoantigenic epitope |
| 01/02/1996 | US5480797 Augmenter of liver regeneration (ALR) |
| 01/02/1996 | US5480796 Antibodies against the receptor protein for human B cell stimulatory factor-2 |
| 01/02/1996 | US5480795 Curculin B and DNA encoding same, and process for production thereof |
| 01/02/1996 | US5480793 Nucleic acid coding for the human angiotensin converting enzyme (ACE), and its uses, especially for the in vitro diagnosis of arterial hypertension |
| 01/02/1996 | US5480782 Process for obtaining cellular protein having anti-HIV activity |
| 01/02/1996 | US5480660 Removal of proteins |
| 01/02/1996 | US5480656 Prolonged release microcapsules |
| 01/02/1996 | US5480644 Collagen for injection in anus |
| 01/02/1996 | US5480640 Alpha interferon for treating prostate cancer |
| 01/02/1996 | US5480378 Apparatus for preparing a concentrate of coagulation factors from a blood sample |
| 01/02/1996 | CA2152981A1 Method of attenuating lung capillary leak in a mammal |
| 01/02/1996 | CA1337891C Anf derivatives with novel bridging |
| 01/02/1996 | CA1337861C De-acyl derivatives of antibiotic a 40926 |
| 12/30/1995 | CA2152233A1 Oligonucleotides to inhibit the expression of isoprenyl protein transferases |
| 12/28/1995 | WO1995035501A1 Cell calcium regulation and its use |
| 12/28/1995 | WO1995035376A2 Polypeptides with interleukin 8 receptor 1 (il8r1) binding domains |
| 12/28/1995 | WO1995035375A1 Interleukin-5 specific recombinant antibodies |
| 12/28/1995 | WO1995035374A1 Human monoclonal antibodies specific to cell cycle independent glioma surface antigen |
| 12/28/1995 | WO1995035373A2 Nucleic acid molecules encoding human contactin |
| 12/28/1995 | WO1995035372A1 5-lipoxygenase-activating protein ii |
| 12/28/1995 | WO1995035370A1 Schistosoma protein and uses thereof |
| 12/28/1995 | WO1995035320A1 High-affinity melatonin receptors and uses thereof |
| 12/28/1995 | WO1995035316A1 New opioid peptide antagonists |
| 12/28/1995 | WO1995035315A1 Gem-disubstituted amino acid derivatives |
| 12/28/1995 | WO1995035314A1 Thiazolidine derivatives, their preparation and drugs containing same |
| 12/28/1995 | WO1995035313A1 3-amino-2-oxo-1-piperidineacetic derivatives containing an arginine mimic as enzyme inhibitors |
| 12/28/1995 | WO1995035312A1 Arginine mimic derivatives as enzyme inhibitors |
| 12/28/1995 | WO1995035311A1 3-amino-2-oxo-1-piperidineacetic derivatives as enzyme inhibitors |
| 12/28/1995 | WO1995035310A1 Pyrrolidine derivatives for the treatment of cholecystokinine and gastrine-related disorders |
| 12/28/1995 | WO1995035309A1 New thrombin inhibitors, their preparation and use |
| 12/28/1995 | WO1995035308A1 INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME |
| 12/28/1995 | WO1995035307A1 Peptide derivatives with metallopeptidase inhibitory activity |
| 12/28/1995 | WO1995035297A1 Novel substituted purinyl derivatives with immunomodulating activity |
| 12/28/1995 | WO1995035280A1 Methods of synthesis of peptidyl argininals |
| 12/28/1995 | WO1995035120A1 Monoclonal antibodies for the reduction of anti-xenogeneic immune responses |
| 12/28/1995 | WO1995035118A1 Contraceptive vaccine |
| 12/28/1995 | WO1995035117A1 Thrombolytic composition |
| 12/28/1995 | WO1995035116A1 Hgh containing pharmaceutical compositions |
| 12/28/1995 | WO1995035115A1 DNA ENCODING AN 18 Kd CDK6 INHIBITING PROTEIN |
| 12/28/1995 | WO1995035112A2 Modulators of pneumococcal adhesion to cellular targets involving the platelet activating factor receptor, and uses thereof |
| 12/28/1995 | WO1995035111A2 USE OF βGalNac(1-4)βGal CONJUGATES TO TREAT CANDIDA INFECTION |
| 12/28/1995 | WO1995035110A1 Administration of pirenzepine, methyl scopolamine and other muscarinic receptor antagonists for treatment of lipid metabolism disorders |
| 12/28/1995 | WO1995035099A1 Vitamin/nutrient dosage regimentation |
| 12/28/1995 | WO1995035085A1 Stimulation of hair growth by peptide-copper complexes |